Phenotype measures set:   Wiltshire4   Tcells_Sel

ID, description, units MPD:52467   Tcells_Sel   T cells, percent viability   [%]
selumetinib study
Measures • dose [µM]:    • control    • 0.046    • 0.137    • 1.235    • 11.1    • 100
Data set, strains Wiltshire4   inbred w/CC7   34 strains     sex: m     age: 10wks
Procedure immune cell quantification
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Wiltshire4 - T cells, percent viability





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 5 64.9804 12.9961 0.7857 0.5602
strain 33 4349.7393 131.8103 7.9691 < 0.0001
dose:strain 165 1902.2288 11.5287 0.697 0.9972
Residuals 594 9824.9155 16.5403

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire4 52467 immune cell quantification selumetinib T cells, percent viability   [%]   control   Tcells_Sel_ctrl inbred w/CC7 34 m 10wks
Wiltshire4 52468 immune cell quantification selumetinib T cells, percent viability   [%]   dose: 0.046 µM   Tcells_Sel_A inbred w/CC7 34 m 10wks
Wiltshire4 52469 immune cell quantification selumetinib T cells, percent viability   [%]   dose: 0.137 µM   Tcells_Sel_B inbred w/CC7 34 m 10wks
Wiltshire4 52470 immune cell quantification selumetinib T cells, percent viability   [%]   dose: 1.235 µM   Tcells_Sel_C inbred w/CC7 34 m 10wks
Wiltshire4 52471 immune cell quantification selumetinib T cells, percent viability   [%]   dose: 11.1 µM   Tcells_Sel_D inbred w/CC7 34 m 10wks
Wiltshire4 52472 immune cell quantification selumetinib T cells, percent viability   [%]   dose: 100 µM   Tcells_Sel_E inbred w/CC7 34 m 10wks